https://orcid.org/0000-0001-8093-8303
References
- Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–192.
- Wang DC, Wei JW, Liu JH, et al. The upper thoracic spinal cord compression as the initial manifestation of Wegener’s granulomatosis: a case report. Eur Spine J. 2007;16(S3):296–300.
- Nishino H, Rubino FA, Parisi JE. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology. 1993;43(7):1334–1337.
- Hiemstra TF, Walsh M, Mahr A, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21):2381–2388.
- Scott TF, Frohman EM, De Seze J, et al. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;77(24):2128–2134.
- Krishnan C, Kaplin A, Deshpande D, et al. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004;9(1–3):1483–1499.
- Gelfand JM. Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. In: Handbook of clinical neurology multiple sclerosis and related disorders. Amsterdam (the Netherlands): Elsevier B.V.; 2014. p. 269–290 (3rd series.).
- Decker ML, Emery DJ, Smyth PS, et al. Microscopic polyangiitis with spinal cord involvement: a case report and review of the literature. J Stroke Cerebrovasc Dis. 2016;25(7):1696–1704.
- Zheng Y, Zhang Y, Cai M, et al. Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know. Front Neurol. 2018;9:1166.
- Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008;28(1):105–120.
- Huh Y, Park EJ, Jung JW, et al. Clinical insights for early detection of acute transverse myelitis in the emergency department. Clin Exp Emerg Med. 2015;2(1):44–50.
- Gómez-Gómez A, Martínez-Martínez MU, Cuevas-Orta E, et al. Pulmonary manifestations of granulomatosis with polyangiitis. Reumatol Clín (English Edn). 2014;10(5):288–293.
- Shah S, Geetha D. Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. Immunotargets Ther. 2015; 4:173–183.
- Martinez V, Cohen P, Pagnoux C, French Vasculitis Study Group, et al. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum. 2008;58(1):308–317.
- Nakazawa M, Suzuki K, Yasuoka H, et al. Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies. Inflamm Regen. 2018;38(1):20–25.